"Saint Alphonsus Regional Medical Center is the region's only level II trauma center. We have a long history and passion of caring for those in need within the hospital and the community as a whole."

During the past decade, Saint Alphonsus Regional Medical Center conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 19 clinical trials were completed, i.e. on average, 55.9% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 14 clinical trials were completed. i.e. 107.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Alphonsus Regional Medical Center" #1 sponsor was "ECOG-ACRIN Cancer Research Group" with 3 trials, followed by "Radiation Therapy Oncology Group" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Medacta USA" with 2 trials sponsored and "National Cancer Institute (NCI)" with 2 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 44 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Alphonsus Regional Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Massachusetts General Hospital" with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator and "Acute Respiratory Distress Syndrome Foundation" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Saint Alphonsus Regional Medical Center" are "Breast Cancer" (6 trials), "Atrial Fibrillation" (3 trials), "Leukemia, Myeloid, Acute" (2 trials), "Neutropenia" (2 trials) and "Osteoarthritis" (2 trials). Many other conditions were trialed in "Saint Alphonsus Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Saint Alphonsus Regional Medical Center" are "Drug" (33 trials), "Device" (15 trials), "Biological" (4 trials), "Procedure" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Cyclophosphamide" (3 trials), "Docetaxel" (3 trials), "Anastrozole" (2 trials) and "Azacitidine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Saint Alphonsus Regional Medical Center" are 45 trials for "All" genders, 6 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Alphonsus Regional Medical Center". undefined are not yet recruiting, 10 are recruiting, 12 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 20 completed trials in Saint Alphonsus Regional Medical Center, 1 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Alphonsus Regional Medical Center, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 10 trials that are defined as “Not Applicable".

Saint Alphonsus Regional Medical Center has several departments that took part in Clinical trials: "Saint Alphonsus Cancer Care Center-Boise" - 376 trials, "Saint Alphonsus Cancer Care Center-Caldwell" - 183 trials